Therapeutic apheresis in kidney transplantation: An updated review

doi:10.5500/wjt.v9.i6.103

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8550)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

954

WORD

298

HTML

5316

Tables (1-2)

229

Sum=6797

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

818

Download

935

Sum=1753

Oct 28, 2019 (publication date) through Sep 4, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Transplant. Oct 28, 2019; 9(6): 103-122
Published online Oct 28, 2019. doi: 10.5500/wjt.v9.i6.103

Table 2 Clinical indications for therapeutic apheresis in kidney transplantation

Desensitization in ABO-i kidney transplantation

Desensitization in patients with preformed HLA-antibodies

Desensitization of deceased donor kidney transplant recipients

Desensitization of living donor kidney transplant recipients

AMR

Recurrence of primary FSGS

Prevention of recurrence and recurrence of complement-mediated aHUS

De novo TMA

Antiphospholipid syndrome and systemic lupus erythematosus

Recurrent and de novo anti-GBM disease

Recurrence of ANCA- AAVs

ABOi: ABO incompatible; HLA: Human leukocyte antigens; AMR: Antibody-mediated rejection; FSGS: Focal segmental glomerulosclerosis; aHUS: Atypical haemolytic uremic syndrome; TMA: Thrombotic microangiopathy; GBM: Glomerular basement membrane; ANCA: Antineutrophil cytoplasmic antibody; AAVs: ANCA associated vasculitis.

Citation: Salvadori M, Tsalouchos A. Therapeutic apheresis in kidney transplantation: An updated review. World J Transplant 2019; 9(6): 103-122
URL: https://www.wjgnet.com/2220-3230/full/v9/i6/103.htm
DOI: https://dx.doi.org/10.5500/wjt.v9.i6.103